Use of Pioglitazone for the Prevention of Radiation-Induced Cognitive Dysfunction

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01151670

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:51.167082+00:00

Published At

2018-08-01T00:00:00+00:00

Record Updated At

2018-08-01

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Brain Neoplasms, Malignant", "Brain Neoplasms, Benign", "Malignant Meningioma", "Glioblastoma Multiforme", "Anaplastic Astrocytoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-08-01"

protocolSection.identificationModule.nctId

"NCT01151670"

protocolSection.identificationModule.officialTitle

"Use of Pioglitazone for the Prevention of Radiation-Induced Cognitive Dysfunction"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Brain Neoplasms, Malignant (protocolSection.conditionsModule.conditions)
• Brain Neoplasms, Benign (protocolSection.conditionsModule.conditions)
• Malignant Meningioma (protocolSection.conditionsModule.conditions)
• Glioblastoma Multiforme (protocolSection.conditionsModule.conditions)
• Anaplastic Astrocytoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.